Search Results

• • 3 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Impact of mineralocorticoid receptor polymorphisms on urinary electrolyte excretion with and without diuretic drugs

  Authors:Nawar Dalila, Jurgen Brockmoller, Mladen Vassilev Tzvetkov, Markus Schirmer, Martin Haubrock, and Stefan Viktor VormfeldeFrom:Pharmacogenomics (Vol. 16, Issue 2) Peer-Reviewed

  Jan. 20156,130 words Report 1500LAuthor(s): Nawar Dalila [*] aff1 , Jürgen Brockmöller aff1 , Mladen Vassilev Tzvetkov aff1 , Markus Schirmer aff1 , Martin Haubrock aff2 , Stefan Viktor Vormfelde aff1 Keywords: antihypertensive agents;...

• Amelogenin-based sex identification as a strategy to control the identity of DNA samples in genetic association studies

  Authors:Mladen Vassilev Tzvetkov, Ingolf Meineke, Daniel Sehrt, Stefan Viktor Vormfelde, and Jurgen BrockmollerFrom:Pharmacogenomics (Vol. 11, Issue 3) Peer-Reviewed

  Mar. 20105,187 words Report Author(s): Mladen Vassilev Tzvetkov [[dagger]] 1 , Ingolf Meineke, Daniel Sehrt, Stefan Viktor Vormfelde, Jürgen Brockmöller KEYWORDS: amelogenin; AMELX ; AMELY ; association studies; PCR-RFLP; quality control;...

• Effects of genetic polymorphisms on the OCT1 and OCT2-mediated uptake of ranitidine

  Authors:Marleen Julia Meyer, Tina Seitz, Jurgen Brockmoller, and Mladen Vassilev TzvetkovFrom:PLoS ONE (Vol. 12, Issue 12) Peer-Reviewed

  Dec. 13, 20179,021 words Report 1410LBackground Ranitidine (Zantac.sup.®) is a H.sub.2 -receptor antagonist commonly used for the treatment of acid-related gastrointestinal diseases. Ranitidine was reported to be a substrate of the organic cation...